Welcome to our dedicated page for Scotts Miracle Gr SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lawn lovers dissect Scotts Miracle-Gro’s fertilizer formulas; indoor cultivators parse Hawthorne hydroponic margins. Yet the financial story behind every bag of Miracle-Gro often hides inside dense disclosures. If you’ve searched “Scotts Miracle-Gro insider trading Form 4 transactions” or wondered how costs shift in a “Scotts Miracle-Gro quarterly earnings report 10-Q filing,” you know the challenge. Stock Titan solves it by delivering Scotts Miracle-Gro SEC filings explained simply, combining EDGAR speed with contextual AI.
Our platform ingests each submission the moment it posts to the SEC, then provides:
- AI-powered summaries that translate legal language into clear takeaways
- Real-time alerts for Scotts Miracle-Gro Form 4 insider transactions real-time
- Side-by-side comparisons so understanding Scotts Miracle-Gro SEC documents with AI becomes second nature
- Segment drill-downs linking hydroponic sales or fertilizer demand directly to the footnotes that matter
Whether you need Scotts Miracle-Gro earnings report filing analysis before the market opens, a Scotts Miracle-Gro annual report 10-K simplified for long-term forecasting, or a deep dive into Scotts Miracle-Gro proxy statement executive compensation, our coverage is exhaustive. We also flag every Scotts Miracle-Gro executive stock transactions Form 4 and keep you informed with Scotts Miracle-Gro 8-K material events explained. From seasonal fertilizer demand swings to evolving cannabis regulations, the insights investors rely on are only a click away.
Scotts Miracle-Gro (SMG) – Form 4 filing: EVP, CFO & CAO Mark J. Scheiwer reported a Code J acquisition on 07/25/2025. He acquired 2.6046 common shares at $57.59, raising his direct holding to 8,336.837 shares. He also holds 433.874 shares indirectly through the company’s 401(k) plan. The filing records no derivative transactions and shows no dispositions. The transaction appears routine and immaterial relative to the executive’s total ownership and the company’s float.
Form 4 highlights: On 07/25/2025, President & COO Nathan E. Baxter—classified as a director, officer and >10 % owner—reported an acquisition of 86.8206 common shares of The Scotts Miracle-Gro Co. (SMG) at $57.59 per share under transaction code “J” (other, non-open-market). Following the transaction, Baxter’s direct holdings rise to 50,689.5047 shares; he also maintains 36,993 shares indirectly through Hagedorn Partnership L.P., where he is a general partner.
No derivative securities were involved and there were no dispositions. The filing notes that Baxter may be deemed a 10 % beneficial owner solely because of his proportional interest in the partnership. With total direct + indirect ownership of roughly 87.7 k shares, Baxter retains significant exposure to SMG’s equity.
Investor take-away: The purchase is modest (<0.2 % of his total stake) and administrative in nature, so market impact should be limited. Nonetheless, the direction of the trade is additive—slightly reinforcing management’s alignment with shareholders—but not large enough to be a strong bullish signal.
Form 4 highlights: On 02/12/2025, Mark J. Scheiwer—EVP, CFO & CAO of The Scotts Miracle-Gro Co. (SMG)—reported selling 1,500 common shares at $66.045 per share (≈$99k gross). After the sale he directly owns 6,834.2324 shares and indirectly holds 433.874 shares via the company 401(k) plan. No derivative trades were disclosed. The filing shows a modest ownership reduction and does not indicate a change in control or strategy.
On 08/04/2025, Hagedorn Partnership, L.P.—a control entity for the Hagedorn family and therefore a 10% owner and related party to several directors/officers—reported two open-market sales of The Scotts Miracle-Gro Company (SMG) common stock.
- 38,314 shares sold at a weighted-average $62.14
- 31,686 shares sold at a weighted-average $62.45
Total shares disposed: 70,000, representing roughly 0.5 % of the Partnership’s direct position. Direct ownership moved from 13,344,274 to 13,274,274 shares. No derivative securities were involved and the filing does not reference a Rule 10b5-1 trading plan.
Additional indirect holdings were disclosed for CEO James Hagedorn (≈79.7 k shares, plus 29.4 k in a 401(k)), Director Katherine Hagedorn Littlefield (6.9 k), and COO Nathan Baxter (50.6 k). The sale size is modest relative to the family’s aggregate stake and appears routine, but it still signals net insider selling.
The Scotts Miracle-Gro Company (SMG) filed an 8-K disclosing a routine board transition. On 31 Jul 2025, Lt. Gen. (ret.) John R. Vines retired from the Board, citing no disagreements with the Company. Vines’ seat was due to expire at the 2027 annual meeting.
Effective 1 Aug 2025, the Board appointed Gen. (ret.) Austin Scott Miller as a Class II director, also naming him to the Nominating & Governance and Innovation & Technology Committees. The Board confirmed that Miller meets NYSE and SEC independence standards and has no material relationships with SMG other than his directorship.
As a non-employee director, Miller will receive prorated 2025 compensation: cash retainers totaling $47,917 and $87,500 in RSUs, which vest on 31 Jan 2026, subject to continued service or accelerated vesting upon death or disability. No other material items, financial statements, or pro forma data were included.
FAQ
What is the current stock price of Scotts Miracle Gr (SMG)?
What is the market cap of Scotts Miracle Gr (SMG)?
